Article

Oncologist Mark Socinski on VeriStrat Testing for Patients With Non-Small Cell Lung Cancer

Lung cancer specialist Mark Socinski, at the University of Pittsburgh Cancer Institute, discusses VeriStrat testing and how it may be useful in the diagnosis of non-small cell lung cancer.

Mark Socinski, co-leader of the lung cancer program at the University of Pittsburgh Cancer Institute, discusses VeriStrat testing and how it may be useful in the diagnosis of non-small cell lung cancer (NSCLC).

VeriStrat is a blood test that examines protein patterns and distinguishes which patients with NSCLC would see minimal benefit from EGFR tyrosine kinase inhibitors, such as Tarceva (erlotinib) and Iressa (gefitinib). Socinski uses results from a VeriStrat test to exclude these choices from a patient’s treatment plan.

The test also includes a prognostic factor, advising practitioners that patients who test VeriStrat “poor" are likely to have a poor prognosis, versus patients who test VeriStrat “good."

Though he does not order VeriStrat testing for all patients in the second and/or third-line setting of NSCLC, Socinski says it is a useful tool.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.